ADDIE H HOLCOMB
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology GULFPORT, MS NPI 1942840368
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology MS Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$4,128.60
- Category: General Payments
- Program years: PY2021–2024
- Record count: 194
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,484.16 across 70 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,385.16 | 69 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $242.38 | 11 |
| Merck Sharp & Dohme Corporation | $135.50 | 7 |
| EISAI INC. | $101.60 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $100.31 | 5 |
| Acerta Pharma LLC | $75.67 | 4 |
| BeiGene USA, Inc. | $74.26 | 3 |
| PharmaEssentia USA Corporation | $63.94 | 3 |
| Lilly USA, LLC | $61.34 | 3 |
| TerSera Therapeutics LLC | $59.75 | 2 |
| Gilead Sciences, Inc. | $57.68 | 2 |
| Celgene Corporation | $55.29 | 2 |
| Daiichi Sankyo Inc. | $44.20 | 2 |
| Incyte Corporation | $44.17 | 2 |
| Genentech USA, Inc. | $43.90 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.93 | 2 |
| Pharmacosmos Therapeutics Inc. | $40.26 | 2 |
| PFIZER INC. | $38.37 | 2 |
| Alexion Pharmaceuticals, Inc. | $36.00 | 2 |
| GlaxoSmithKline, LLC. | $24.71 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.98 | 1 |
| SOBI, INC | $19.15 | 1 |
| AVEO Pharmaceuticals, Inc. | $17.69 | 1 |
| Rigel Pharmaceuticals, Inc. | $17.64 | 1 |
| ABBVIE INC. | $16.73 | 1 |
| Deciphera Pharmaceuticals Inc. | $16.09 | 1 |
| Genmab U.S., Inc. | $15.98 | 1 |
| Tempus AI, Inc | $15.64 | 1 |
By program year
Records — PY2024 (70)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.